Campbell CY - Search Results

1

Metabolic syndrome, subclinical coronary atherosclerosis, and cardiovascular risk.

Campbell CY, Nasir K, Blumenthal RS. Campbell CY, et al. Am Heart Hosp J. 2005 Spring;3(2):105-10. doi: 10.1111/j.1541-9215.2005.04441.x. Am Heart Hosp J. 2005. PMID: 15860997 Review.

2

The association of subclinical coronary atherosclerosis with abdominal and total obesity in asymptomatic men.

Nasir K, Campbell CY, Santos RD, Roguin A, Braunstein JB, Carvalho JA, Blumenthal RS. Nasir K, et al. Among authors: campbell cy. Prev Cardiol. 2005 Summer;8(3):143-8. doi: 10.1111/j.1520-037x.2005.4362.x. Prev Cardiol. 2005. PMID: 16034216 Free article.

3

C-reactive protein in cardiovascular risk assessment: a review of the evidence.

Abraham J, Campbell CY, Cheema A, Gluckman TJ, Blumenthal RS, Danyi P. Abraham J, et al. Among authors: campbell cy. J Cardiometab Syndr. 2007 Spring;2(2):119-23. doi: 10.1111/j.1559-4564.2007.05950.x. J Cardiometab Syndr. 2007. PMID: 17684461 Review.

4

Combined effect of high low-density lipoprotein cholesterol and metabolic syndrome on subclinical coronary atherosclerosis in white men without clinical evidence of myocardial ischemia.

Campbell CY, Nasir K, Sarwar A, Meneghelo RS, Carvalho JA, Blumenthal RS, Santos RD. Campbell CY, et al. Am J Cardiol. 2007 Sep 1;100(5):840-3. doi: 10.1016/j.amjcard.2007.04.018. Epub 2007 Jun 18. Am J Cardiol. 2007. PMID: 17719330

5

Residual risk in statin-treated patients: future therapeutic options.

Campbell CY, Rivera JJ, Blumenthal RS. Campbell CY, et al. Curr Cardiol Rep. 2007 Nov;9(6):499-505. doi: 10.1007/BF02938395. Curr Cardiol Rep. 2007. PMID: 17999876 Review.

6

The metabolic syndrome adds incremental value to the Framingham risk score in identifying asymptomatic individuals with higher degrees of inflammation.

Campbell CY, Nasir K, Carvalho JA, Blumenthal RS, Santos RD. Campbell CY, et al. J Cardiometab Syndr. 2008 Winter;3(1):7-11. doi: 10.1111/j.1559-4572.2008.06670.x. J Cardiometab Syndr. 2008. PMID: 18326979

7

Role of atherosclerosis assessment and other novel markers in the metabolic syndrome.

Campbell CY, Nasir K, Wong ND, Blumenthal RS. Campbell CY, et al. Metab Syndr Relat Disord. 2006 Winter;4(4):261-9. doi: 10.1089/met.2006.4.261. Metab Syndr Relat Disord. 2006. PMID: 18370745

8

Coronary artery calcification and inflammation according to various metabolic syndrome definitions.

Narla V, Santos RD, Campbell CY, Carvalho JA, Nasir K, Budoff MJ, Blumenthal RS, Michos ED. Narla V, et al. Among authors: campbell cy. J Cardiometab Syndr. 2009 Winter;4(1):33-9. doi: 10.1111/j.1559-4572.2008.00033.x. J Cardiometab Syndr. 2009. PMID: 19245514

9

The use of high-sensitivity assays for C-reactive protein in clinical practice.

Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ, Lange RA, Topol EJ, Willerson JT, Desai MY, Davidson MH, Mora S. Musunuru K, et al. Among authors: campbell cy. Nat Clin Pract Cardiovasc Med. 2008 Oct;5(10):621-35. doi: 10.1038/ncpcardio1322. Epub 2008 Aug 19. Nat Clin Pract Cardiovasc Med. 2008. PMID: 18711404 Free PMC article. Review.

10

Waiting for the National Cholesterol Education Program Adult Treatment Panel IV Guidelines, and in the meantime, some challenges and recommendations.

Martin SS, Metkus TS, Horne A, Blaha MJ, Hasan R, Campbell CY, Yousuf O, Joshi P, Kaul S, Miller M, Michos ED, Jones SR, Gluckman TJ, Cannon CP, Sperling LS, Blumenthal RS. Martin SS, et al. Among authors: campbell cy. Am J Cardiol. 2012 Jul 15;110(2):307-13. doi: 10.1016/j.amjcard.2012.03.023. Epub 2012 Apr 10. Am J Cardiol. 2012. PMID: 22497674

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page